Pricing Log in Create free account

NexImmune, Inc. (NEXI) vs Silo Pharma, Inc. (SILO)

NexImmune, Inc. and Silo Pharma, Inc. are both Biotechnology companies. Silo Pharma, Inc. is the larger, with a market value of $1.9M against $1.6M — 1.2× the size. Across the 8 metrics below, Silo Pharma, Inc. leads on 5 and NexImmune, Inc. on 3.

Valuation

Metric NEXI SILO Biotechnology median
P/E n/m n/m 8.50
P/S n/m 18.00 9.71
P/B n/m 0.27 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m 0.90 0.64
EV/Sales n/m (54.56) 9.21
Earnings yield 0.00% (369.34%) (33.15%)
Free cash flow yield 0.00% (302.55%) (25.50%)

Profitability

Metric NEXI SILO Biotechnology median
Gross margin 0.00% 11.81% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (232.97%) (91.23%) (56.36%)
Return on assets (140.56%) (70.96%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric NEXI SILO Biotechnology median
Revenue growth (TTM) — 0.00% 6.02%
EPS growth (last fiscal year) 52.58% 57.98% 30.26%
Revenue growth, 5-year CAGR — 12.17% 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric NEXI SILO Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 0.66 5.36 4.72
Net debt to EBITDA 0.10 1.61 0.96

Dividend

Metric NEXI SILO Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric NEXI SILO Biotechnology median
Market cap 1.60m 1.91m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack